about
sameAs
Navigating the Zika panicZika in the United States: How Are We Preparing?Assessing the global threat from Zika virusThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisEnvironmental and Social Change Drive the Explosive Emergence of Zika Virus in the AmericasEnhancement of Zika virus pathogenesis by preexisting antiflavivirus immunityFlavivirus cross-reactivity in serological tests and Guillain-Barré syndrome in a hematopoietic stem cell transplant patient: A case reportBiologic Evidence Required for Zika Disease Enhancement by Dengue AntibodiesVaccination strategies against Zika virusVariable inhibition of Zika virus replication by different Wolbachia strains in mosquito cell culturesZika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A ReviewHistorical Perspectives on Flavivirus ResearchCharacterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer ModelingVaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus.Zika Virus Research Models.Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells.In vitro-engineered non-antibody protein therapeutics.Viral Load and Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed Zika Virus-Infected Patients.Flavivirus cross-reactivity, Guillain-Barré syndrome, and hematopoietic stem cell transplant patient: Comment response.In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations.Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge.Suggested mechanisms for Zika virus causing microcephaly: what do the genomes tell us?Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.Sustained specific and cross-reactive T cell responses to Zika and Dengue viruses NS3 in West Africa.Development of Antibody Therapeutics against Flaviviruses.Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic Development.Congenital Zika virus infection as a silent pathology with loss of neurogenic output in the fetal brain.Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection InVitro and in a Mouse Model.The immunology of Zika Virus.Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?Genome-Wide Analysis to Identify HLA Factors Potentially Associated With Severe Dengue.Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.Probing Molecular Insights into Zika Virus⁻Host Interactions.BgTEP: An Antiprotease Involved in Innate Immune Sensing in Biomphalaria glabrata.Autoimmune Neurological Conditions Associated With Zika Virus Infection.Biochemistry and Molecular Biology of Flaviviruses.Zika might not be acting alone: Using an ecological study approach to investigate potential co-acting risk factors for an unusual pattern of microcephaly in Brazil
P2860
Q26247567-B963DBA0-C4B3-4F5A-8E2F-3F75F0308F25Q26970792-C73A5784-3E74-418A-B864-65EF7496F27CQ27010603-67121C66-40DC-46CB-BCE0-A46395FDFC24Q28804225-06204472-10A9-4BCD-BDA2-DBB4B4CC0ADDQ28804239-2CCEF9D1-2EC0-4BD1-9B41-F147BC4893DDQ29196526-2B83CB69-3A60-4936-BDB8-E0384F9FA38EQ29365325-3ADD52B8-FAB0-4A04-B8F6-34E61F00DE15Q29365355-2746D377-0BAE-4E4B-BD84-F46EEA37694EQ29571224-ABD8F851-25B4-4921-8F0B-CC66EFF52AE9Q29587266-F52DE356-6B47-44C4-8FC8-9E88C78194EBQ29647477-0EA3754D-0D33-4291-8FBD-3198E51B7697Q29994534-AFA3BC85-9758-462C-A3D4-67CB5BA1AAA0Q30145645-A0CAC8B5-5359-43C6-BFC9-B44DA7E4A033Q33780548-D84F1141-8469-4CE3-9BC8-1C1752F28D32Q38156536-46B275BD-5BCE-4ACE-A9C8-FE3C6FB2E3CDQ38156586-DBFED0A7-0A3F-41CC-92CE-1F227CC443BBQ38156734-B90AC064-971A-4A25-82B7-4A314E0786FAQ38157432-98DC6C14-07E8-4978-8A63-DA9A62B732F5Q39167522-ADE6D931-FFC8-474E-A421-C847E629AE5EQ41920081-057F3144-7137-4544-857A-8C8E27B781E3Q43038325-96DC718C-9CB0-4A4F-9E79-A58F8210F8CAQ45324353-CB443AD4-A257-491D-B0CB-A87E9A8A2E59Q45324929-DE5CBC86-D09F-4653-83C2-BD880DF36E08Q47159692-9E2487A7-3283-48B9-9B90-40EC1A3D7972Q47549528-4538D8D1-72EA-424C-B5EC-40805A2BED29Q47550067-BA40F7EE-5425-4A80-9311-ADC9F2A08C5BQ47555900-0FFBE291-260B-4116-B3BF-466900E93FE0Q47558158-DFACDEFC-E650-4AE2-B690-7C199F62C673Q47558305-FB483EC7-FC73-4A90-9F7C-EBE96D618027Q48106134-076F1726-D7B0-4CC1-AE55-3D66D7BC7AE4Q50052067-F18AD6E2-9BF6-461C-99EE-C4F2CAC2F46EQ51336389-418FF1FF-9F75-4316-BD1F-BE654A38026DQ51336586-B5EC5FA1-D3AC-42BF-A189-AC08BC2DED9EQ52310308-C7902E14-4F9E-4A93-8102-792BAB96939DQ54217627-27F3BC8B-E584-4AE2-BF0F-D2C5E0906476Q54221789-33E02CC6-68AC-4A34-8A3B-ED1AAF1878C6Q55025811-9AB49FB3-7EF6-47A4-B7BE-E85D16A36AB2Q55026039-314CC6CD-C067-49DF-AE9E-F9A4DC739151Q55277816-3340AC77-0074-45D2-893E-ED88E8FEABABQ56340348-BE305C11-3707-4A7B-88E8-C5F9BC6AEDD2
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Dengue virus antibodies enhance Zika virus infection
@ast
Dengue virus antibodies enhance Zika virus infection
@en
Dengue virus antibodies enhance Zika virus infection
@nl
type
label
Dengue virus antibodies enhance Zika virus infection
@ast
Dengue virus antibodies enhance Zika virus infection
@en
Dengue virus antibodies enhance Zika virus infection
@nl
prefLabel
Dengue virus antibodies enhance Zika virus infection
@ast
Dengue virus antibodies enhance Zika virus infection
@en
Dengue virus antibodies enhance Zika virus infection
@nl
P2093
P2860
P50
P921
P356
P1476
Dengue virus antibodies enhance Zika virus infection
@en
P2093
Carolyn M Barcellona
Cindo O Nicholson
Eric R Carlin
Meagan M Jenkins
P2860
P356
10.1038/CTI.2016.72
P577
2016-12-16T00:00:00Z